COMMUNIQUÉS West-GlobeNewswire

-
Yield10 Bioscience to Host Webcast of its Third Quarter 2018 Conference Call
30/10/2018 -
Ultragenyx to Host Conference Call for Third Quarter 2018 Financial Results and Corporate Update
30/10/2018 -
Bloomberg Interviews FSD Pharma for Cannabis Shortage Feature -- CFN Media
30/10/2018 -
Biodesix Advances ORACLE Registry for Lung Nodule Cancer Test
30/10/2018 -
RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST NINE MONTHS 2018. REVENUES +5.1%, EBITDA +11.1%, OPERATING INCOME +9.6%, NET INCOME +8.2%. INTERIM DIVIDEND € 0.45 (+7.1%)
30/10/2018 -
The Foundation for Women’s Cancer and TESARO Partner on the Race to End Women’s Cancer for 3rd Year
30/10/2018 -
Leading BioSciences Announces Appointments of James R. Neal and James Sapirstein to Board of Directors
30/10/2018 -
Iovance Biotherapeutics to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Tuesday, November 6, 2018
30/10/2018 -
Immune Design to Report Third Quarter 2018 Financial Results and Provide Corporate Update
30/10/2018 -
InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6
30/10/2018 -
Daré Announces Two Late-Breaking Abstracts to be Presented at the American Association of Pharmaceutical Scientists (AAPS) in Washington D.C.
30/10/2018 -
electroCore, Inc. Announces Appointment of Ardelle Ferris as Vice President of Managed Care
30/10/2018 -
Navicent Health Adopts iCAD’s Breast Cancer Detection and Therapy Solutions to Enhance Patient Care
30/10/2018 -
Shore Group Invests $6M in Healthcare AI Data Startup H1
30/10/2018 -
ContraVir Pharmaceuticals Completes Final Cohort Dosing in CRV431 Drug-Drug Interaction Study
30/10/2018 -
Mustang Bio Announces Updates on CAR T Cell Therapy Clinical Trials with City of Hope
30/10/2018 -
Pascal Biosciences and the University of Washington Enter Into Exclusive License Agreement to Develop Cannabinoid-based Medicine for Cancer
30/10/2018 -
CymaBay Announces the Initiation of the Seladelpar Global Phase 3 Registration Study (ENHANCE) for the Treatment of Primary Biliary Cholangitis and Additional Corporate Updates
30/10/2018 -
Cue Biopharma Announces Presentation at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
30/10/2018
Pages